D1 receptors mediate dopamine action in the fetal suprachiasmatic nuclei: studies of mice with targeted deletion of the D1 dopamine receptor gene

Brain Res Mol Brain Res. 1997 Oct 3;49(1-2):271-7. doi: 10.1016/s0169-328x(97)00161-7.

Abstract

Studies in rodents suggest the presence of a dopaminergic system that influences the function of a biological clock in the hypothalamic suprachiasmatic nuclei (SCN). To provide insights into mechanisms of dopamine action in the SCN, we studied transgenic mice that had either one allele (+¿-) or both alleles (-/-) of the D1 dopamine receptor gene deleted, along with normal (+/+) littermates. As expected, receptor labelling autoradiography studies using [125I]SCH 23982 showed a complete absence of D1 dopamine receptor binding sites in the SCN of -/- animals. When pregnant mice from +¿- x +¿- matings were injected with the D1 receptor agonist SKF 38393, or the dopamine reuptake blocker GBR 12909 at day 19 of gestation, c-fos mRNA expression was observed in the SCN of +/+ fetuses. In contrast, c-fos mRNA induction was not seen in -/- or +¿- litter mates. Injection of cocaine into pregnant dams also resulted in robust SCN c-fos mRNA expression in +/+ mice. Increases in SCN c-fos mRNA expression were also seen in +¿- and -/- mice suggesting that cocaine action in the SCN involves both D1 receptor-dependent and -independent mechanisms. Collectively, our studies of transgenic mice deficient in D1 receptors support the presence of a functional dopaminergic system in the fetal SCN. We also identify D1 receptors as the prominent transducer of dopamine action in the fetal SCN.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Animals
  • Autoradiography
  • Benzazepines / analogs & derivatives
  • Benzazepines / metabolism
  • Cocaine / pharmacology
  • Crosses, Genetic
  • Dopamine / physiology*
  • Dopamine Agonists / pharmacology
  • Dopamine Antagonists / metabolism
  • Dopamine Uptake Inhibitors / pharmacology
  • Female
  • Fetus
  • Male
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Piperazines / pharmacology
  • Pregnancy
  • Proto-Oncogene Proteins c-fos / biosynthesis
  • RNA, Messenger / biosynthesis
  • Receptors, Dopamine D1 / deficiency
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D1 / physiology*
  • Signal Transduction
  • Suprachiasmatic Nucleus / embryology
  • Suprachiasmatic Nucleus / physiology*
  • Transcription, Genetic / drug effects
  • Tritium

Substances

  • 8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol
  • Benzazepines
  • Dopamine Agonists
  • Dopamine Antagonists
  • Dopamine Uptake Inhibitors
  • Piperazines
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • Receptors, Dopamine D1
  • Tritium
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • vanoxerine
  • Cocaine
  • Dopamine